Cetera Advisor Networks’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $25.7M | Sell |
926,653
-25
| -0% | -$694 | 0.13% | 164 |
|
|
2023
Q4 | $26.7M | Sell |
926,678
-34,401
| -4% | -$1.04M | 0.15% | 141 |
|
|
2023
Q3 | $31.9M | Buy |
961,079
+34,094
| +4% | +$1.21M | 0.2% | 110 |
|
|
2023
Q2 | $34M | Buy |
926,985
+21,943
| +2% | +$854K | 0.24% | 90 |
|
|
2023
Q1 | $36.9M | Buy |
905,042
+30,218
| +3% | +$1.31M | 0.27% | 79 |
|
|
2022
Q4 | $44.8M | Buy |
874,824
+146,982
| +20% | +$7.05M | 0.36% | 50 |
|
|
2022
Q3 | $31.9M | Buy |
727,842
+74,881
| +11% | +$3.64M | 0.4% | 39 |
|
|
2022
Q2 | $34.2M | Buy |
652,961
+28,270
| +5% | +$1.44M | 0.44% | 38 |
|
|
2022
Q1 | $32.3M | Buy |
624,691
+11,838
| +2% | +$614K | 0.39% | 45 |
|
|
2021
Q4 | $36.2M | Sell |
612,853
-12,062
| -2% | -$598K | 0.44% | 35 |
|
|
2021
Q3 | $26.9M | Buy |
624,915
+8,109
| +1% | +$359K | 0.36% | 52 |
|
|
2021
Q2 | $24.2M | Buy |
616,806
+172,124
| +39% | +$6.69M | 0.34% | 54 |
|
|
2021
Q1 | $16.1M | Buy |
444,682
+48,354
| +12% | +$1.72M | 0.34% | 61 |
|
|
2020
Q4 | $14.6M | Sell |
396,328
-32,644
| -8% | -$1.2M | 0.34% | 60 |
|
|
2020
Q3 | $14.9M | Buy |
428,972
+21,004
| +5% | +$736K | 0.39% | 51 |
|
|
2020
Q2 | $12.7M | Sell |
407,968
-2,625
| -0.6% | -$89.2K | 0.34% | 60 |
|
|
2020
Q1 | $12.7M | Buy |
410,593
+14,105
| +4% | +$481K | 0.42% | 54 |
|
|
2019
Q4 | $14.8M | Buy |
396,488
+4,503
| +1% | +$160K | 0.4% | 53 |
|
|
2019
Q3 | $13.4M | Sell |
391,985
-18,115
| -4% | -$659K | 0.4% | 53 |
|
|
2019
Q2 | $16.8M | Buy |
410,100
+9,885
| +2% | +$393K | 0.52% | 46 |
|
|
2019
Q1 | $16.1M | Buy |
400,215
+6,508
| +2% | +$261K | 0.52% | 45 |
|
|
2018
Q4 | $16.3M | Buy |
393,707
+19,081
| +5% | +$792K | 0.63% | 31 |
|
|
2018
Q3 | $15.7M | Buy |
374,626
+36,167
| +11% | +$1.39M | 0.54% | 39 |
|
|
2018
Q2 | $11.7M | Sell |
338,459
-13,156
| -4% | -$450K | 0.58% | 34 |
|
|
2018
Q1 | $11.9M | Buy |
351,615
+3,546
| +1% | +$122K | 0.52% | 39 |
|
|
2017
Q4 | $12M | Sell |
348,069
-5,334
| -2% | -$182K | 0.5% | 42 |
|
|
2017
Q3 | $12M | Buy |
353,403
+68
| +0% | +$2.19K | 0.54% | 39 |
|
|
2017
Q2 | $11.3M | Sell |
353,335
-7,144
| -2% | -$225K | 0.53% | 43 |
|
|
2017
Q1 | $11.7M | Buy |
360,479
+10,043
| +3% | +$317K | 0.56% | 40 |
|
|
2016
Q4 | $10.8M | Sell |
350,436
-90,416
| -21% | -$2.76M | 0.56% | 38 |
|
|
2016
Q3 | $14.2M | Buy |
440,852
+125,322
| +40% | +$4.19M | 0.54% | 38 |
|
|
2016
Q2 | $10.6M | Buy |
315,530
+11,010
| +4% | +$351K | 0.61% | 32 |
|
|
2016
Q1 | $8.56M | Buy |
304,520
+8,504
| +3% | +$243K | 0.53% | 38 |
|
|
2015
Q4 | $9.06M | Sell |
296,016
-22,172
| -7% | -$698K | 0.58% | 31 |
|
|
2015
Q3 | $9.47M | Buy |
318,188
+9,268
| +3% | +$297K | 0.65% | 29 |
|
|
2015
Q2 | $10.2M | Hold |
308,920
| – | – | 0.65% | 31 |
|
|
2015
Q1 | $10.2M | Buy |
308,920
+1,451
| +0.5% | +$46.1K | 0.65% | 31 |
|
|
2014
Q4 | $9.08M | Sell |
307,469
-16,844
| -5% | -$483K | 0.64% | 31 |
|
|
2014
Q3 | $9.11M | Sell |
324,313
-20,780
| -6% | -$583K | 0.62% | 32 |
|
|
2014
Q2 | $9.72M | Sell |
345,093
-30,774
| -8% | -$877K | 0.64% | 25 |
|
|
2014
Q1 | $11.4M | Buy |
375,867
+5,020
| +1% | +$150K | 0.82% | 22 |
|
|
2013
Q4 | $10.8M | Buy |
370,847
+6,426
| +2% | +$187K | 0.82% | 21 |
|
|
2013
Q3 | $9.93M | Buy |
364,421
+27,945
| +8% | +$760K | 0.86% | 20 |
|
|
2013
Q2 | $8.96M | Buy |
+336,476
| New | +$9.3M | 0.89% | 21 |
|
Other funds holding PFE
Cetera Advisor Networks's PFE Position: Q1 2024 in Review
Cetera Advisor Networks reduced its Pfizer (PFE) stake by 0% in Q1 2024, selling an estimated $694 and leaving 926,653 shares worth $25.7M. The position accounts for 0.13% of the portfolio, ranked #164.
Cetera Advisor Networks first reported a position in PFE in Q2 2013 and has held it in 44 quarters since. The position peaked at $44.8M in Q4 2022. 2,875 funds tracked by Wall St. Rank hold PFE as of Q1 2024.
- Cetera Advisor Networks held 926,653 shares of Pfizer worth $25.7M as of Q1 2024.
- Cetera Advisor Networks sold 25 Pfizer shares in Q1 2024, an estimated $694.
- Pfizer made up 0.13% of Cetera Advisor Networks's portfolio in Q1 2024, its #164 holding.
- Cetera Advisor Networks first reported a position in Pfizer in Q2 2013 and has held it in 44 quarters since.
- Cetera Advisor Networks's Pfizer position peaked at $44.8M in Q4 2022.
- 2,875 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.
Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.